Balko, J. M., Giltnane, J. M., Wang, K., Schwarz, L. J., Young, C. D., Cook, R. S., . . . Arteaga, C. L. (2013). Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.
Styl cytowania ChicagoBalko, Justin M., et al. Molecular Profiling of the Residual Disease of Triple-negative Breast Cancers After Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets. 2013.
Styl cytowania MLABalko, Justin M., et al. Molecular Profiling of the Residual Disease of Triple-negative Breast Cancers After Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets. 2013.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..